Visomes Competitors

Eureka Therapeutics is a privately held biotechnology company located in the San Francisco Bay Area, focused on breakthrough immunotherapies for the treatment of cancer. Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pipeline of innovative drugs, with the most advanced candidates at pre-clinical stage. Eureka Therapeutics is a leader in the discovery of novel antibody immunotherapies. We utilize a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancer antigens. In collaboration with Memorial Sloan-Kettering Cancer Center, we were the first-to-demonstrate in vivo efficacy of a human IgG1 antibody against an intracellular cancer antigen. Our most advanced program is at preclinical stage and being developed in partnership with Novartis.

Advanced Pharma is a nationwide 503B registered, FDA inspected Outsourcing facility for Low-Medium Risk compounding needs. Advanced Pharma is one of the largest, most advanced Outsourcing facilities in the nation. Advanced Pharma provides services throughout the United States and has strategic partnerships within the pharmaceutical industry to produce and deliver products and services to Hospital pharmacy systems in a responsive, fluid manner. Our national partners receive the same expedient, attentive service they would receive by a local provider. Advanced Pharma is compliant in all aspects of FDA, DEA, and State Board of Pharmacy regulations, and actively participates in the development of guidelines and standards for our ever changing industry.

MaxBio is aiming to bring innovative technologies /products from middle and small life science companies to the fastest growing emerging markets by leveraging MaxBio’s local knowledge, long-term relationship, superior marketing talent, state-of-the-art R&D facility and manufacturing infrastructure in China.